Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Bateman

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
Journal of Medical Genetics|November 1, 1996
The phenotypic features of osteogenesis imperfecta resulting from a mutation of the carboxyl-terminal pro alpha 1 (I) propeptide that impairs the assembly of type I procollagen and formation of the extracellular matrixW G Cole, C W Chow, J F Bateman, et al.
Human Mutation|January 1, 1992
Lethal perinatal osteogenesis imperfecta due to a type I collagen alpha 2(I) Gly to Arg substitution detected by chemical cleavage of an mRNA:cDNA sequence mismatchJ F Bateman, I Moeller, M Hannagan, et al.
The Biochemical Journal|November 15, 1992
Characterization of three osteogenesis imperfecta collagen alpha 1(I) glycine to serine mutations demonstrating a position-dependent gradient of phenotypic severityJ F Bateman, I Moeller, M Hannagan, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Biochemical heterogeneity of type I collagen mutations in osteogenesis imperfectaJ F Bateman, D Chan, S Lamande, et al.
Analytical Biochemistry|December 1, 1989
Detection and localization of base changes in RNA using a chemical cleavage methodH H Dahl, S R Lamande, R G Cotton, et al.
Connective Tissue Research|January 1, 1989
Collagen protein abnormalities produced by site-directed mutagenesis of the pro alpha 1(I) geneJ F Bateman, T Mascara, W G Cole, et al.
Journal of Medical Genetics|September 1, 1990
The clinical features of osteogenesis imperfecta resulting from a non-functional carboxy terminal pro alpha 1(I) propeptide of type I procollagen and a severe deficiency of normal type I collagen in tissuesW G Cole, P E Campbell, J G Rogers, et al.
Annals of the New York Academy of Sciences|January 1, 1990
The study of collagen structure and function by site-directed mutagenesis of collagen genesJ F Bateman, T Mascara, W G Cole, et al.
Journal of Medical Genetics|April 1, 1990
The clinical features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by arginine in the pro alpha 1(I) chain of type I procollagenW G Cole, C W Chow, J G Rogers, et al.
Immunology and Cell Biology|February 1, 1990
Antibodies to type II collagen in SLE: a role in the pathogenesis of deforming arthritis?E K Choi, P A Gatenby, J F Bateman, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
Journal of Medical Genetics|November 1, 1996
The phenotypic features of osteogenesis imperfecta resulting from a mutation of the carboxyl-terminal pro alpha 1 (I) propeptide that impairs the assembly of type I procollagen and formation of the extracellular matrixW G Cole, C W Chow, J F Bateman, et al.
Human Mutation|January 1, 1992
Lethal perinatal osteogenesis imperfecta due to a type I collagen alpha 2(I) Gly to Arg substitution detected by chemical cleavage of an mRNA:cDNA sequence mismatchJ F Bateman, I Moeller, M Hannagan, et al.
The Biochemical Journal|November 15, 1992
Characterization of three osteogenesis imperfecta collagen alpha 1(I) glycine to serine mutations demonstrating a position-dependent gradient of phenotypic severityJ F Bateman, I Moeller, M Hannagan, et al.
Annals of the New York Academy of Sciences|January 1, 1988
Biochemical heterogeneity of type I collagen mutations in osteogenesis imperfectaJ F Bateman, D Chan, S Lamande, et al.
Analytical Biochemistry|December 1, 1989
Detection and localization of base changes in RNA using a chemical cleavage methodH H Dahl, S R Lamande, R G Cotton, et al.
Connective Tissue Research|January 1, 1989
Collagen protein abnormalities produced by site-directed mutagenesis of the pro alpha 1(I) geneJ F Bateman, T Mascara, W G Cole, et al.
Journal of Medical Genetics|September 1, 1990
The clinical features of osteogenesis imperfecta resulting from a non-functional carboxy terminal pro alpha 1(I) propeptide of type I procollagen and a severe deficiency of normal type I collagen in tissuesW G Cole, P E Campbell, J G Rogers, et al.
Annals of the New York Academy of Sciences|January 1, 1990
The study of collagen structure and function by site-directed mutagenesis of collagen genesJ F Bateman, T Mascara, W G Cole, et al.
Journal of Medical Genetics|April 1, 1990
The clinical features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by arginine in the pro alpha 1(I) chain of type I procollagenW G Cole, C W Chow, J G Rogers, et al.
Immunology and Cell Biology|February 1, 1990
Antibodies to type II collagen in SLE: a role in the pathogenesis of deforming arthritis?E K Choi, P A Gatenby, J F Bateman, et al.
Pageof 10